Patent Board Institutes Inter Partes Review Of Allergan Patent

Mealey's (August 30, 2018, 12:38 PM EDT) -- ALEXANDRIA, Va. — An Amneal Pharmaceuticals LLC challenge to a patent covering the dermatologic drug dapsone will proceed before the Patent Trial and Appeal Board, which instituted inter partes review on...
To view the full article, register now.